India’s pharmaceutical sector is entering a transformative phase with the Biopharma SHAKTI initiative announced in Budget 2026.
This strategic move is set to strengthen domestic manufacturing, accelerate biologics innovation, and position India as a global biopharma hub.
At Hab Pharma, we welcome this progressive step that empowers pharma companies and supports long-term healthcare growth.